Mr. Yeh Liang Tsai | Medical Clinical Practice | Best Researcher Award

Attending Physician at Changhua Christian Hospital, Taiwan

Dr. Liang-Tsai Yeh is an accomplished clinical researcher and healthcare professional with a dual role as an Attending Physician in the Department of Anesthesiology at Changhua Christian Hospital and as an Assistant Professor at the Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan. With over three decades of clinical experience and a deep involvement in academic medicine, Dr. Yeh has consistently contributed to the advancement of medical science through clinical practice, academic mentorship, and impactful research. His work spans critical care, cardiovascular outcomes, anesthesiology, and infectious diseases, particularly focusing on post-COVID-19 complications and therapeutic strategies.

Profile

Orcid

Education

Dr. Yeh received his formal medical training and postgraduate education from Chung Shan Medical University, Taichung, where he later pursued both his Master’s and Ph.D. degrees in medical sciences. His commitment to lifelong learning is evidenced by his transition into academic roles at National Chung Hsing University, where he has served as a faculty member since May 2022. This solid educational foundation has been pivotal to his dual-track career in hospital-based medicine and academic research. Through both institutions, he has built a robust understanding of both clinical applications and the underlying scientific methodologies critical for translational medicine.

Experience

Since July 1992, Dr. Yeh has served as an Attending Physician in the Department of Anesthesiology at Changhua Christian Hospital, one of Taiwan’s leading healthcare institutions. In this role, he has managed high-risk surgical procedures, led anesthetic protocols, and contributed to hospital-based quality improvement initiatives. Concurrently, he holds a deputy directorial position in the same department, overseeing operational excellence and guiding clinical staff. His role in academia, particularly at National Chung Hsing University, has included curriculum development, research mentorship, and fostering interdisciplinary collaborations. This blend of hands-on clinical care and academic leadership underscores his holistic approach to medicine.

Research Interest

Dr. Yeh’s research interests are wide-ranging, encompassing anesthesiology, post-surgical recovery, thromboembolic risks, cardiovascular medicine, and public health outcomes, particularly in the context of chronic diseases and COVID-19. A notable aspect of his work includes investigating the long-term risks of mortality and vascular events among post-operative patients and those affected by COVID-19. He has also explored pharmacologic interventions, such as the effects of tranexamic acid and the implications of benzodiazepine usage. His studies often leverage large-scale population-based cohort data and retrospective designs, aiming to inform policy, clinical practice, and preventive strategies.

Award

Dr. Yeh has demonstrated excellence in both clinical and academic medicine and has become a recognized figure in research on vascular complications, pharmacologic therapies, and COVID-19 outcomes. Though specific awards are not listed in the provided details, his consistent publication in high-impact journals and leadership in hospital and university settings indicate recognition and respect in his field. His ongoing commitment to evidence-based practice and translational research positions him as a strong candidate for the Excellence in Research Award.

Publication

Dr. Liang-Tsai Yeh has co-authored numerous peer-reviewed journal articles. Seven representative publications include:

  1. Exploring the incidence of peripheral arterial occlusive disease following COVID-19 infection, Journal of Medical Virology, 2024, cited by 12 articles.

  2. Long-Term Risk of All-Cause Mortality and Major Adverse Cardiovascular Events in Hip Osteoarthritis Patients, SSRN, 2024, cited by 9 articles.

  3. Association between psoriasis and peripheral artery occlusive disease, Frontiers in Cardiovascular Medicine, 2023, cited by 11 articles.

  4. Dose–response association of benzodiazepine use and development of deep vein thrombosis, Psychiatry Research, 2023, cited by 15 articles.

  5. Mortality Risk in Intracranial Hemorrhage Patients with Tranexamic Acid Treatment, SSRN, 2023, cited by 8 articles.

  6. Assessing Continuous Epidural Infusion in Labor Analgesia, Medicina, 2023, cited by 6 articles.

  7. Association of Glaucoma with Peripheral Arterial Occlusive Disease, Journal of Clinical Medicine, 2023, cited by 10 articles.

These publications reflect Dr. Yeh’s interdisciplinary research scope and strong citation metrics.

Conclusion

Dr. Liang-Tsai Yeh exemplifies the ideal combination of clinician, educator, and researcher. His long-standing dedication to patient care, teaching, and impactful research has significantly influenced both clinical practices and public health understanding in Taiwan and beyond. With expertise in anesthesiology, post-operative outcomes, and chronic disease management, his work stands out for its relevance and rigor. Dr. Yeh’s scholarly productivity, academic mentorship, and hospital leadership make him a deserving nominee for recognition in the Excellence in Research Award category. His contributions continue to pave the way for evidence-based improvements in health care delivery and medical education.

Yeh Liang Tsai | Medical Clinical Practice | Best Researcher Award

You May Also Like